Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020

Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects.

News | Congenital Heart | May 21, 2020
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were...
Rash on the skin of a child who has COVID-19 related multi-system inflammatory syndrome (MIS-C). Image copyright Damien Bonnet, M.D., Ph.D., courtesy of the American Heart Association. Coronavirus is linked with this Kawasaki-like inflammatory disease in children.

Rash on the skin of a child who has COVID-19 related multi-system inflammatory syndrome (MIS-C). The image is from  Damien Bonnet, M.D., Ph.D., Necker Hospital-Université, Paris, who was involved in a Circulation study published on MIS-C May 14. Image copyright Damien Bonnet, courtesy of the American Heart Association.

Feature | Coronavirus (COVID-19) | May 20, 2020 | Dave Fornell, Editor
A new, serious COVID-19 cardiovascular presentation emerged in late April and early May 2020 in the form of pediatric...
HRS 2020 Late-Breaking Clinical Trials in Electrophyiology
Feature | HRS | May 20, 2020
May 20, 2020 — Here is the complete list of late-breaking clinical trials (LBCT)  and links to articles on all of them...
he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

News | EP Lab | May 20, 2020
May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of...
PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the...
Results of the Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study at HRS 2020. #HRS2020 #Heartrhythm2020,
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking...
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
News | EP Lab | May 19, 2020
May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT),...
A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.

A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.

News | Artificial Intelligence | May 19, 2020
May 19, 2020 — Artificial intelligence (AI) may be an aid to interpreting ECG results, helping healthcare staff to...
Mayo Clinic is using artificial intelligence EchoGo Core software from Ultromics to automatically analyize echocardiography images to assess the cardiac impact of COVID-19. The AI software is from Ultromics.

Mayo Clinic is using artificial intelligence EchoGo Core software from Ultromics to automatically analyize echocardiography images to assess the cardiac impact of COVID-19.

News | Coronavirus (COVID-19) | May 19, 2020
May 19, 2020 — A joint U.K.-U.S. research team is applying a pioneering artificial intelligence (AI) system to...
Videos | Coronavirus (COVID-19) | May 18, 2020
Marianne Pop, Pharm.D., BCPS, a clinical pharmacist and clinical assistant professor with the regional pharmacy program...
Edwards Lifesciences Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe
News | Heart Valve Technology | May 18, 2020
May 18, 2020 — The Edwards Lifesciences Corp. Pascal tricuspid transcatheter valve repair (TTVR) system received...
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or...
ISCHEMIA Trial: Patients With Intermediate Left Main Coronary Disease Have Worse Cardiovascular Events. #SCAI2020
News | SCAI | May 17, 2020
May 17, 2020 – A new study shows that when compared with patients without intermediate left main coronary artery...
CD34+ Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction. #SCAI2020
News | May 17, 2020
May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to...
Icosapent Ethyl (Vascepa) significantly Reduces Revascularizations in Statin Patients in the REDUCE-IT REVASC analyses presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

Icosapent Ethyl (Vascepa) significantly reduces revascularizations in statin patients based on data from the REDUCE-IT REVASC analyses, presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

News | Pharmaceuticals | May 17, 2020
May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy....